Note Market Direction, but Also Look Further<br />By Rev Shark<br />RealMoney.com Contributor<br />3/3/2010 8:35 AM EST<br /><br /> Eschew the monumental. Shun the epic. All the guys who can paint great big pictures can paint great small ones.<br /> -- Ernest Hemmingway<br /><br />When I first started trading, I paid little attention to overall market direction. I focused on individual stock-picking and didn't much care what the major indices were doing. Even when the market was moving against me, I could still do quite well if I was in the right stocks.<br /><br />Over time I came to realize that I could enhance my returns if my level of aggressiveness was correlated with the market trend. Generally about 80% of stocks will move in the same direction of the overall market, so obviously it's going to be tougher to make money if you fight the trend.<br /><br />The problem is that you miss out on opportunities if you focus too much on overall market direction. There are two issues here. The most dangerous is that if you are wrong about market direction you will have needlessly sold stocks that may have done nothing wrong. If you are too black-and-white about being bearish and bullish based on the overall indices, you are going to find yourself very poorly positioned quite often.<br /><br />The second problem is that the overall indices often cover up strong themes and sectors that are working well. As Jim Cramer says, there is always a bull market somewhere. At times there may not be much of one, but at other times you can have some great-performing stocks when the indices don't look so great.<br /><br />I bring this up because it is so easy to be caught up in labels like "bullish" and "bearish." Even if we are quite pessimistic about market direction we can still be holding long positions and vice versa. Good trading isn't just about having one opinion about the overall market; it is about managing a number of individual positions within the context of a shifting environment. You don't want to be blind to overall market direction, because it is going to have a large impact on what your stocks do, but you don't want to be so slavish to it that you are holding nothing when you are negative about the indices.<br /><br />I take gains into strength, and that helps me navigate the market. I automatically become less bullish the more extended the market becomes. If I keep finding good individual charts I will add them and still have long positions even as I grow more concerned about a shift in market direction.<br /><br />It is very convenient to use labels like "bullish" and "bearish," but it is a very poor trading methodology. I've been concerned that the market is becoming extended and vulnerable for a reversal soon, but if I just sold everything and started loading up on shorts I would have missed out on the gains in stocks that are acting well. On the other hand, if I keep loading up with no regard for the dangers of a reversal, I'll cost myself a very big chunk of recent profits.<br /><br />We have a fairly flat open on the way, but we are extended and the risks of a reversal are increasing. I still have some long positions but they are shrinking fast as I lock in gains when I have them.<br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: AMCF +18.0%, LSCC +11.4%, NPD +9.5% (light volume), MFB +8.9%, ETH +8.9%, HSNI +3.7%, HOV +3.3%, JOYG +3.1%, URS +3.0% (light volume), SCLN +2.9%, GFRE +1.8%, CISG +1.6% ... M&A news: SWWC +50.6% (signs agreement to be acquired by Long-Term Infrastructure Investor Group for $11 per share), NOVL +27.7% (Elliott Offers to Acquire Novell for $5.75 per share in cash, which implies an enterprise value net of cash of $1.0 bln), LOV +10.2% (announces formation of a Special Committee to evaluate acquisition proposal at $3.10/share)... Select financial names showing strength: PUK +4.1%, BCS +3.1%, UBS +1.6%, DB +1.2%... Select metals/mining related names trading higher: GFI +1.9%, RTP +1.7%, AU +1.7%, SLV +1.4%, MT +1.4%, ABX +1.4%, HMY +1.4%, GDX +1.3%, MT +1.3%, SLW +1.0%, GLD +0.5%... Other news: ELN +4.2% (seeing continued strength), RNN +3.4% (submits Zoraxel Phase IIb protocol to FDA), JDSU +2.6% (Cramer makes positive comments on MadMoney), TM +2.1% (following strength in overseas trading), BT +1.6% (still checking), IBKC +0.9% (priced a ~5.19 mln share common stock offering at $57.75/share)... Analyst comments: DAN +5.6% (added to Conviction Buy list at Goldman), CLU +3.7% (initiated with Overweight at JPMorgan), BX +2.8% (upgraded to Outperform at Oppenheimer), AKAM +1.2% (upgraded to Buy at Merriman), UPS +1.0% (initiated with Buy at Goldman), FCX +0.9% (upgraded to Outperform at RBC), LECO +0.9% (upgraded to Outperform at Barrington Research).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance/SSS: VISN -26.2% (also Susquehanna downgraded to Negative from Neutral and Piper downgraded to Neutral from Overweight), CT -18.1%, CMED -9.4%, PAY -6.0%, JAKK -5.8%, APSG -4.9%, NKTR -4.9%, BJ -2.9%, COST -2.2%, BIG -1.6%... Other news: MDVN -67.7% amd PFE -0.5% (Medivation and Pfizer announce results from two Phase 3 Studies in Dimebon Alzheimer's Disease clinical development program study, Dimebon does not meet primary and secondary), CPNO -4.9% (announces public offering of 6.3 mln common units), PTNR -4.7% (trading ex dividend), SNV -4.3% (facing informal SEC inquiry: Filing - Reuters), MSSR -4.2% (still checking), IRE -4.2% (still checking), NBG -3.8% (S&P says less pessimistic than markets on Greece - Reuters), CTRP -2.5% (files 6-K announcing secondary offering of 5.7 mln ADS), PNNT -1.7% (prices public offering at $10.00), GENZ -1.4% (Genzyme and PTC Therapeutics announce preliminary results from the Phase 2b clinical trial of Ataluren; primary endpoint of change in 6-minute walk distance did not reach statistical significance within the 48-week duration of the study)... Analyst comments: NFLX -4.3% (downgraded to Underperform at BofA/Merrill, downgraded to Neutral at Susquehanna, downgraded to Hold at Kaufman), CHRW -3.2% (initiated with a Sell at Goldman), ANN -2.5% (downgraded to Hold at Jesup & Lamont based on valuation), CSX -1.4% (initiated with a Sell at Goldman), SPLS -1.1% (downgraded to Neutral at Goldman), BIDU -0.9% (Hearing downgraded to Neutral at UBS).